Bernante, Antonio T.

HRN: 23-57-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
CEFTRIAXONE 1G (VIAL)
01/07/2025
01/13/2025
IVT
2g
OD
Cholelithiasis
Waiting Final Action 
01/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2025
01/07/2025
IV
4.5g
Once
Massive Ascites
Waiting Final Action 
01/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/07/2025
01/14/2025
IV
2.25g
Every 6 Hours
Massive Ascites
Waiting Final Action 
01/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/07/2025
01/14/2025
IV
500mg
Q6h
Massive Ascites
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: